Serotypes of Streptococcus pneumoniae causing major pneumococcal infections

First in Russia prospective non-interventional hospital-based study on Streptococcus pneumoniae serotypes causing meningitis and acute otitis media (AOM) in children and community-acquired pneumonia (CAP) in children and adults, as well as serotype coverage by pneumococcal conjugate vaccines (PCV’s) of different composition has been conducted. Serotypes 19F, 14 and serogroup 6 are the leading in meningitis; serotype coverage is 70,6% for PCV7, and 76,5% – for PCV10 and PCV13. Among S. pneumoniae serotypes causing AOM 19F, 3, 23F and serogroup 6 have been the most prevalent in Saint Petersburg. PCV7 and PCV10 provide equal serotypes coverage in AOM – 63,2% among children 0–2 years old, and 32,5% among children 5–17 years old. PCV13 covers up to 79% of serotypes in infants. In CAP PCV7 and PCV10 provide 57,1% serotype coverage in children and 56,1% – in adults. Serotype coverage in CAP for PCV13 has been 14,3% and 34,5% higher for children and adults, correspondingly. Obtained data supports PCV inclusion in children immunization program in Saint Petersburg, whereas PCV13 provides the broadest serotype coverage. In the course PCV’s implementation continued pneumococcal infection surveillance is advisable.

1. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper // Wkly Epidemiol Rec. – 2012. – V. 87 (14). – Р. 129–144.

2. Pilishvili, T. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine / T. Pilishvili [et al.] //J. Infect. Dis. – 2010. – V. 201 (1). – P. 32–41.

3. McIntosh, E.D. Global prevailing and emerging pediatric pneumococcal serotypes / E.D. McIntosh, R.R. Reinert //Expert. Rev. Vaccines. – 2011. – V. 10 (1). – P. 109–129.

4. Gene, A. Pneumococcal Serotypes causing Acute Otitis Media among Children in Barcelona (1992–2011): Emergence of the Multi-Resistant Clone ST320 of Serotype 19A / A. Gene [et al.] // Pediatr. Infect. Dis. J. – 2012. – Р. 25–31.

5. Shibl, A.M. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA) / A.M. Shibl, Z.A. Memish, K.M. Al-Kattan //Vaccine. – 2012. – V. 30, Suppl 6. – P. G32–6.

6. Richter, S.S. Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999-2011(1.) / S.S. Richter [et al.] // Emerg Infect Dis. – 2013. – V. 19 (7). – P. 1074–1083.

7. Miller, E. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine / E. Miller. [et al.] //Vaccine. – 2011. – V. 29 (49). – P. 9127–9131.

8. Prymula, R. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix /R. Prymula, L. Schuerman // Expert Rev Vaccines. – 2009. – V. 8 (11). – P. 1479–1500.

9. Summary of product characteristics Synflorix, 2012.

10. Simell, B. The fundamental link between pneumococcal carriage and disease / B. Simell [et al.] // Expert. Rev. Vaccines. – 2012. – V. 11 (7). – P. 841–855.

11. Pai, R. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates / R. Pai, R.E. Gertz, B. Beall // J. Clin. Microbiol. – 2006. – V. 44 (1). – P. 124–131.

12. van Hoek, A.J. Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes / A.J. van Hoek [et al.] // PLoS One. – 2012. – V. 7 (7). – P. e39150.

13. Koroleva, I.S. Epidemiological characteristics of pneumococcal meningitis in children aged under 6 years of age in the Russian Federation / I.S. Koroleva, G.V. Beloshitskiy //Epidemiology and Infectious Diseases. Comprehensive issues. – 2012. – V. 1. – P. 18–21.

14. R., D., Serotype-specific Incidence (PCV7 and PCV13 Serotypes) in Children <24m with MEF Culture, Southern Israel, 2004-2012. 2013: not published.

15. Rodgers, G.L. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines / G.L. Rodgers [et al.] // Vaccine. – 2009. – Р. 161–177.

16. Маянский, Н.А. Бактериальная этиология острого среднего отита у детей до 5 лет: роль Streptococcus pneumoniаe / Н.А. Маянский [и др.] // Вопросы диагностики в педиатрии. – 2013. – № 5 (3). – С. 5–13.

17. Hackel, M. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations / M. Hackel. [et al.] // Vaccine. – 2013. – Р. 25–29.